Philip Morris stock holds near $194 as Q3 earnings guidance supports outlook
Published on 08/27/2026 at 21:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Philip Morris International Inc. (ISIN US7181721090) stock is trading close to $193.94 as of August 27, 2026, with investors digesting the company’s latest quarterly results, earnings guidance and dividend profile.
Recent earnings beat and guidance
Per a recent earnings overview for Philip Morris International, the company reported adjusted earnings per share of $2.20 for the second quarter of 2026, ahead of a consensus estimate of $2.05 and indicating a $0.15 earnings beat for the period ended in June 2026. This same source shows that revenue in the quarter totaled $11.19 billion, coming in above analyst expectations of $10.60 billion and marking a 10.4 percent increase compared with the prior-year quarter, when revenue was $10.13 billion. The report also notes that net margin stood at 11.06 percent, while return on equity was negative at 163.41 percent, reflecting the company’s leveraged capital structure even as operating performance remained solid.
In that Q2 2026 update, the company set guidance for third-quarter 2026 earnings at an EPS range of $2.20 to $2.25. With consensus estimates for the full fiscal year indicating expected earnings of 8.33 per share in 2026, the implied run rate suggests that management and analysts see room for continued profit growth from the Q2 2026 base. The earnings release further highlighted a quarterly dividend of $1.47 per share, corresponding to an annualized payout of $5.88 and a dividend yield of 3.0 percent at prevailing share prices at the time of the announcement. For income-focused investors, that combination of mid-single-digit yield and mid-teens earnings growth compared with the prior year provides a tangible valuation anchor.
Market data compiled in late August 2026 show that Philip Morris International shares opened at $193.94 on the New York Stock Exchange in the most recent trading session cited. The same data indicate a one-year trading range between $142.11 on the low end and $207.76 at the high, placing the current quote in the upper half of that band. From the start of the year through late August 2026, performance figures for related listings suggest that the stock has gained more than 20 percent on a year-to-date basis, aligning the name with other global tobacco and consumer-staples companies that have benefited from defensive cash flows and steady dividend growth.
Analyst consensus and institutional interest
Several institutional transaction summaries dated August 27, 2026, point to ongoing interest from wealth managers and asset managers in Philip Morris International shares. One portfolio disclosure notes that an investment adviser acquired 8,061 shares valued at $1,465,000 in a recent period, implying a purchase price in the region of $181.72 per share for that block. Other filings reference new positions such as 5,720 shares valued at $1.04 million and larger allocations over 17,500 shares, underscoring the stock’s role as a core income and defensive growth holding in multi-asset portfolios.
Across these reports, the compiled analyst view shows that the stock carries a consensus rating described as Moderate Buy and an average twelve-month price target of $205.89. With the New York listing quoted at $193.94 as of August 27, 2026, the consensus target implies upside potential of approximately 6.2 percent from that level, excluding dividends. Relative to the one-year high of $207.76 cited in the same market overview, the consensus target also sits modestly below peak price action observed over the last twelve months, suggesting that most analysts view the shares as fairly valued to slightly undervalued rather than pricing in a significant re-rating.
The Q2 2026 earnings beat and raised guidance appear to underpin this supportive analyst stance. Revenue growth of 10.4 percent year-over-year off a $10.13 billion prior-year base is noteworthy for a mature tobacco company and reflects the continued shift toward smoke-free products such as heated tobacco systems, alongside geographic expansion. The EPS increase from $1.89 in the same quarter a year earlier to $2.20 in Q2 2026 represents a 16.4 percent rise, outpacing revenue growth and indicating operating leverage as higher-margin products become a larger share of the portfolio. For investors comparing Philip Morris International with regional peers, this combination of double-digit top-line growth and mid-teens EPS growth stands out within the global tobacco universe.
Regulatory backdrop and smoke-free strategy
A recent investigative article dated August 27, 2026, notes that a senior European Union watchdog has opened a probe into undisclosed meetings between European Commission officials and representatives of major tobacco manufacturers, including Philip Morris International and another multinational peer. The inquiry focuses on whether these interactions complied with transparency rules and public-health commitments aimed at reducing tobacco-related harm. While Philip Morris International did not provide a public comment in that report, the development signals that regulatory scrutiny of legacy tobacco operations remains intense, especially in regions that have adopted strict frameworks such as the World Health Organization’s Framework Convention on Tobacco Control.
This regulatory environment forms the backdrop for Philip Morris International’s long-running strategy to pivot toward smoke-free products. Company communications and investor presentations have emphasized the ambition to generate a majority of revenue from non-combustible products, including heated tobacco devices and associated consumables. In recent quarters, the revenue growth cited in the Q2 2026 earnings overview has been driven in significant part by adoption of these smoke-free platforms across Europe, Asia and selected emerging markets. That shift has implications for margins, capital expenditure and regulatory risk, as the company seeks to position its portfolio in categories that regulators may treat differently from conventional cigarettes.
From an investor perspective, the regulatory investigation in Europe and the company’s transformation strategy are intertwined. On one hand, heightened oversight can constrain promotional activities and product placement for traditional cigarettes; on the other, success in moving consumers to smoke-free alternatives can support volume stability and pricing power even in markets where cigarette volumes are declining. The revenue and EPS growth figures in Q2 2026 suggest that, at least for now, Philip Morris International is managing this transition while still delivering earnings upside relative to expectations, a balance that informs the Moderate Buy consensus rating and the mid-single-digit price-target premium to the current share price.
IQOS as a flagship product
Within Philip Morris International’s smoke-free portfolio, the IQOS heated tobacco system remains the flagship product and a key driver of reported growth. IQOS devices heat specially designed tobacco sticks to release nicotine-containing aerosol without combustion, which the company positions as a potentially reduced-exposure alternative for adult smokers who would otherwise continue smoking. Over the last several years, IQOS has been rolled out in numerous European Union countries, Japan and other Asian markets, and in selected markets under licensing or commercial agreements.
Adoption metrics for IQOS have been highlighted regularly in the company’s investor materials, with references to tens of millions of adult users who have switched from cigarettes to IQOS in markets where the product is available. In markets like Japan, the shift has been particularly pronounced, with heated tobacco products gaining substantial market share and contributing meaningfully to Philip Morris International’s revenue mix. In the Q2 2026 earnings data, the strong 10.4 percent year-over-year revenue growth and 16.4 percent EPS growth likely reflect continued expansion of IQOS and related consumables, alongside price and mix changes in traditional combustible categories.
For investors evaluating IQOS as part of the investment thesis in late August 2026, the key factors include regulatory acceptance, scientific evidence submitted by the company regarding risk reduction, and competitive dynamics in heated tobacco and e-vapor segments. While the European watchdog investigation underscores that regulators remain vigilant regarding tobacco industry influence, it does not directly target the smoke-free product category itself. As a result, the growth trajectory of IQOS and similar products remains a central variable in whether Philip Morris International can sustain the type of double-digit revenue growth and mid-teens EPS expansion highlighted in the latest quarterly numbers.
Shares trade within upper range
Philip Morris International shares are listed on the New York Stock Exchange under the ticker PM, with the latest cited opening price of $193.94 as of August 27, 2026. That level sits comfortably above the one-year low of $142.11 and modestly below the one-year high of $207.76, giving the stock a trading profile in the upper portion of its 12-month range. Applying the annualized dividend of $5.88 per share to the $193.94 price implies a cash dividend yield of 3.0 percent, a level that remains competitive against other global consumer-staples and tobacco names while leaving room for potential dividend growth in future years if earnings continue to track the 8.33 EPS consensus for fiscal 2026.
With consensus price targets clustered around $205.89, the current share price offers limited but visible upside when compared to analyst expectations, and the valuation is further supported by the company’s strong cash generation, ongoing share demand from institutional investors and the strategic pivot toward smoke-free products led by IQOS. For retail investors looking at Philip Morris International on August 27, 2026, the picture is one of a mature but evolving tobacco company whose stock combines income characteristics with measured growth, trading close to recent highs yet backed by earnings and guidance that have, so far, met or exceeded market forecasts.
Read more
More detailed information on Philip Morris International’s strategy, earnings and product portfolio is available via the company’s investor relations website at Philip Morris International investor relations, where the latest presentations and regulatory filings can be consulted.
IQOS heated tobacco system
IQOS, as Philip Morris International’s leading heated tobacco system, exemplifies the company’s effort to create a smoke-free future by offering adult smokers an alternative to traditional cigarettes that eliminates combustion and reduces the formation of certain harmful chemicals. The device works in tandem with specially designed tobacco sticks, integrating electronics, temperature control and user-friendly design to encourage switching behavior among established smokers. In markets where IQOS has been available for several years, sales data and category share suggest that it has become a significant driver of revenue and a cornerstone of the company’s long-term transformation story.
Philip Morris stock and investor view
As of August 27, 2026, Philip Morris International stock on the New York Stock Exchange is cited with an opening price of $193.94 per share, within a documented one-year trading interval from $142.11 to $207.76. This positioning, combined with an annualized dividend of $5.88 and a yield of 3.0 percent, frames the shares as a blend of income and growth exposure anchored by the company’s Q2 2026 earnings beat and Q3 2026 EPS guidance in the $2.20 to $2.25 range.
Fact box
Company: Philip Morris International Inc.
ISIN: US7181721090
Ticker: PM
Exchange: New York Stock Exchange
Price (as of August 27, 2026, opening): $193.94 USD
Market cap: Not specified in the cited sources
Sector / Industry: Consumer staples / Tobacco
Index membership: S&P 500
